Literature DB >> 22064519

How CD95 stimulates invasion.

Ernst J A Steller1, Inne H M Borel Rinkes, Onno Kranenburg.   

Abstract

CD95 is best known for its capacity to induce apoptosis, but also activates multiple non-apoptotic signalling pathways. In particular, CD95 promotes migration and tissue invasion of apoptosis-resistant cell types, and this plays a central role in inflammation, neurobiology, and tumor biology. CD95 induces invasion by stimulating the expression of extracellular matrix (ECM)-degrading proteases, and by stimulating the formation of actin-driven cell protrusions through Rac and the cofilin pathway. In this review we discuss how CD95-initiated signalling pathways may cooperate to facilitate cell migration and tissue invasion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064519     DOI: 10.4161/cc.10.22.18290

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  CD95 rs1800682 polymorphism and cervical cancer risk: evidence from a meta-analysis.

Authors:  Yan Zhang; Shengchun Tong; Lihua Guan; Fei Na; Wei Zhao; Li Wei
Journal:  Tumour Biol       Date:  2013-10-11

2.  Mice lacking functional CD95-ligand display reduced proliferation of the intestinal epithelium without gross homeostatic alterations.

Authors:  Kari Trumpi; Ernst J A Steller; Wendy W de Leng; Daniëlle A Raats; Isaäc J Nijman; Folkert H M Morsink; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  Med Mol Morphol       Date:  2015-12-23       Impact factor: 2.309

3.  Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.

Authors:  Qiuyan Liu; Qinchun Tan; Yuanyuan Zheng; Kun Chen; Cheng Qian; Nan Li; Qingqing Wang; Xuetao Cao
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

Review 4.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

Review 5.  Membrane trafficking of death receptors: implications on signalling.

Authors:  Wulf Schneider-Brachert; Ulrike Heigl; Martin Ehrenschwender
Journal:  Int J Mol Sci       Date:  2013-07-11       Impact factor: 5.923

6.  Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro.

Authors:  Christian Merz; Alexander Strecker; Jaromir Sykora; Oliver Hill; Harald Fricke; Peter Angel; Christian Gieffers; Heike Peterziel
Journal:  Anticancer Drugs       Date:  2015-08       Impact factor: 2.248

7.  CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.

Authors:  Danielle A Raats; Nicola Frenkel; Susanne J van Schelven; Inne HMBorel Rinkes; Jamila Laoukili; Onno Kranenburg
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

Review 8.  Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.

Authors:  Vesna Risso; Elodie Lafont; Matthieu Le Gallo
Journal:  Cell Death Dis       Date:  2022-03-17       Impact factor: 9.685

9.  The actin cytoskeleton as a sensor and mediator of apoptosis.

Authors:  Melissa Desouza; Peter W Gunning; Justine R Stehn
Journal:  Bioarchitecture       Date:  2012-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.